Next™ CAR-T Therapy Development
The development of cell and gene therapy treatments has revolutionized our perception of possible treatments for disease. The potential treatments for deadly diseases has brought valuable hope to many people, and this is what Creative Biolabs recognizes and is committed to supporting.
Creative Biolabs' Cellular and Gene Therapy team is dedicated to solving unique challenges in cell and gene therapy manufacturing and non-clinical research. We can provide data, expertise, and comprehensive services to meet your needs in the entire development path of cell and gene therapy.
Leading Experience and Solutions
As a comprehensive provider of cellular and gene therapy services, Creative Biolabs' team of scientists captures critical clinical information during drug development to support real-time monitoring of products throughout the supply chain.
-
Evaluate the specific needs of cell and gene therapy, develop customized GMP manufacturing plans, reduce complexity, time and risk
-
Develop a regulatory strategy to promote successful IND / IND pre-conferences and achieve rapid planning
-
Prepare a target product profile to guide the development plan and communicate product attributes to stakeholders
-
Perform pre-clinical testing, including extensive zoology in vivo functional experiments
-
Fast turnaround and transit time
One-Stop Cellular and Gene Therapy Services
Animal Models
Animal models enable researchers to better study pathological processes and develop therapeutic drugs by simulating disease state of living organisms. Creative Biolabs' network of professional management and breeding facilities adheres to the most stringent biosafety measures. Our scientists rely on our extensive portfolio of animal models to help our clients to achieve optimal research results.
Learn More >
Cell Line Characterization
According to document ICH Q5D ‘Quality of Biological Products: Derivatives and Characterization of Cellular Substrates for the Production of Biotechnology/Biological Products’, Creative Biolabs performs cell bank characterization on the following cell lines:
Learn More >
-
Master Cell Banks (MCB)
-
Working Cell Banks (WCB)
-
End-of-Production Cells (EOPC)
-
Virus Seed Stock (VSS)
Cell and gene therapy is characterized by individuality, vitality, and valuable value. The understanding of and dealing with these features has given the confidence to scientists of Creative Biolabs’ team in the development of cell and gene therapy therapies for cancer.
Creative Biolabs will work with you on the road of drug discovery. Please for free to contact us for more detailed information.
For Research Use Only | Not For Clinical Use
Related Services
Download our brochure